Sanjivani Paranteral Limited (BOM:531569)
144.00
+0.95 (0.66%)
At close: Jul 10, 2026
Sanjivani Paranteral Market Cap
Sanjivani Paranteral has a market cap or net worth of 1.77 billion as of July 10, 2026. Its market cap has decreased by -32.95% in one year.
Market Cap
1.77B
Enterprise Value
1.92B
Revenue
686.66M
Ranking
n/a
PE Ratio
26.23
Stock Price
144.00
Market Cap Chart
Since October 17, 2007, Sanjivani Paranteral's market cap has increased from 200.84M to 1.77B, an increase of 780.78%. That is a compound annual growth rate of 12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.77B | -37.81% |
| Dec 31, 2025 | 2.84B | -38.37% |
| Dec 31, 2024 | 4.62B | 119.33% |
| Dec 29, 2023 | 2.10B | 441.05% |
| Dec 30, 2022 | 388.93M | 3.46% |
| Dec 31, 2021 | 375.94M | 526.71% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 2, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gennex Laboratories | 2.41B |
| Ambalal Sarabhai Enterprises | 2.36B |
| Kerala Ayurveda | 2.15B |
| Coral Laboratories | 2.14B |
| Sat Kartar Life | 2.11B |
| Oxygenta Pharmaceutical | 1.79B |
| Accretion Pharmaceuticals | 1.75B |
| Parnax Lab | 1.64B |